首站-论文投稿智能助手
典型文献
Qilan preparation(芪蓝颗粒)inhibits proliferation and induces apoptosis by down-regulating microRNA-21 in human Tca8113 tongue squamous cell carcinoma cells
文献摘要:
OBJECTIVE:The aim of this study was to examine the antitumor effects of Qilan preparation(芪蓝颗粒)on oral squamous cell carcinoma(OSCC)in vitro and to investigate its underlying mechanisms of action.METHODS:Cell proliferation,cell cycle distribution and apoptosis were examined using cell counting kit-8(CCK8)and flow cytometry(FCM).The expression of PTEN and PDCD4 were determined by western blot.Changes in miR-21 levels were quantified using TaqMan stem-loop real-time PCR.After miR-21 was transiently transfected into Tca8113 cells using Lipofectamine?3000,cell proliferation,apoptosis and miR-21 and PDCD4 expression levels were measured.RESULTS:Qilan preparation inhibited Tca8113 cell growth in a dose-and time-dependent manner by inducing apoptosis and cell cycle arrest in S-phase,decreasing miR-21 levels and increasing PTEN and PDCD4 expression.MiR-21 overexpression reversed the Qilan preparation-induced suppression of cell proliferation and induction of apoptosis while also blocking the increase in PDCD4.CONCLUSIONS:Our study revealed,for the first time,the ability of Qilan preparation to suppress TSCC cell growth and elucidated that Qilan preparation elicits its anti-cancer actions via either the miR-21/PDCD4 or PTEN pathway.
文献关键词:
作者姓名:
DING Jiamin;XING Yifeng;CHEN Zuoliang;CHEN Wanlu;MA Zhongxiong;XIE Yunde;ZHOU Lin
作者机构:
Department of Oral Mucosal Diseases,Affiliated Stomatological Hospital of Fujian Medical University,Fuzhou 350000,China;School and Hospital of Stomatology,Fujian Medical University,Fuzhou 350000,China;Department of Oral Mucosal Diseases,Xiamen Stomatological Hospital,School of Stomatology,Fujian Medical University,Xiamen 361003,China;Department of Implantology,Affiliated Stomatological Hospital of Fujian Medical University,Fuzhou 350001,China
引用格式:
[1]DING Jiamin;XING Yifeng;CHEN Zuoliang;CHEN Wanlu;MA Zhongxiong;XIE Yunde;ZHOU Lin-.Qilan preparation(芪蓝颗粒)inhibits proliferation and induces apoptosis by down-regulating microRNA-21 in human Tca8113 tongue squamous cell carcinoma cells)[J].中医杂志(英文版),2022(05):693-700
A类:
Qilan
B类:
preparation,inhibits,proliferation,induces,apoptosis,by,down,regulating,microRNA,human,Tca8113,tongue,squamous,carcinoma,cells,OBJECTIVE,aim,this,study,was,antitumor,effects,oral,OSCC,vitro,investigate,underlying,mechanisms,METHODS,Cell,cycle,distribution,were,examined,using,counting,kit,CCK8,flow,cytometry,FCM,PTEN,PDCD4,determined,western,blot,Changes,miR,levels,quantified,TaqMan,stem,loop,real,After,transiently,transfected,into,Lipofectamine,measured,RESULTS,inhibited,growth,dose,dependent,manner,inducing,arrest,phase,decreasing,increasing,MiR,overexpression,reversed,induced,suppression,induction,while,also,blocking,increase,CONCLUSIONS,Our,revealed,first,ability,TSCC,elucidated,that,elicits,cancer,actions,via,either,pathway
AB值:
0.533751
相似文献
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
Jingrong Xian;Shiwen Wang;Yanyu Jiang;Lihui Li;Lili Cai;Ping Chen;Yue Liu;Xiaofei Zeng;Guoan Chen;Chen Ding;Robert M.Hoffman;Lijun Jia;Hu Zhao;Yanmei Zhang-Department of Laboratory Medicine,Huadong Hospital Affiliated to Fudan University,Shanghai 200040,China;Cancer Institute,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Research Center on Aging and Medicine,Fudan University,Shanghai 200040,China;Shanghai Key Laboratory of Clinical Geriatric Medicine,Shanghai 200040,China;Department of Basic Science of Oncology,College of Basic Medical Sciences,Zhengzhou University,Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;School of Medicine,Southern University of Science and Technology,Shenzhen 518055,China;State Key Laboratory of Genetic Engineering,Human Phenome Institute,Institutes of Biomedical Sciences,School of Life Sciences,Zhongshan Hospital,Fudan University,Shanghai 200032,China;State Key Laboratory of Cell Differentiation and Regulation,Henan International Joint Laboratory of Pulmonary Fibrosis,Henan Center for Outstanding Overseas Scientists of Pulmonary Fibrosis,College of Life Science,Institute of Biomedical Science,Henan Normal University,Xinxiang 453007,China;Department of Surgery,University of California,San Diego 92101,USA;Anticancer Inc.,San Diego 92101,USA
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
Zhang Weiwei;Yan Wenji;Qian Niansong;Han Quanli;Zhang Weitao;Dai Guanghai-Chinese People’s Liberation Army Medical School, Beijing 100853, China;Department of the Third Health Care, The Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The Hainan Medical Center, Chinese People’s Liberation Army General Hospital, Sanya 572022, China;Cancer Center, Beijing Tongren Hospital Affiliated to Capital Medical University, Economic and Technological Development Zone, Beijing 100176, China
Methyl gallate isolated from Mangifera pajang kernel induces proliferation inhibition and apoptosis in MCF-7 breast cancer cells via oxidative stress
Ranneh Yazan;Abu Bakar Mohd Fadzelly;Rahim Azlen-Che;Kassim Nur Kartinee;Stanslas Johnson;Teh Yuan-Han;Fadel Abdulmannan;Ellulu Mohammed S-Department of Technology and Natural Resources,Faculty of Applied Science and Technology,Universiti Tun Hussein Onn Malaysia,Pagoh Campus,KM1 Panchor Road,Muar Johor,Malaysia;Department of Chemistry,Faculty of Science,Universiti Putra Malaysia,Serdang 43300,Malaysia;Department of Medicine,Faculty of Medicine and Health Sciences,Universiti Putra Malaysia,Selangor,Malaysia;Sport and Exercises Sciences School,Faculty of Science,Liverpool John Moores University,Liverpool,UK;Department of Clinical Nutrition,Faculty of Applied Medical Sciences,Al-Azhar University of Gaza,Gaza City,State of Palestine
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。